Table 4. Clinical symptoms associated with pathogens.
Complaints of symptoms prior to hospitalization collected during enrollment. Bolded value with asterisk indicates the value is significantly different from patients without the indicated pathogen. Clinical symptoms were compared for patients with different infectious etiologies as described above. All tests of statistical significance were two-tailed, and significance was defined as p<0.05.
| Symptom | None (N = 107) |
B. pseudomallei (N = 23) |
Dengue virus (N = 21) |
O. tsutsugamushi (N = 16) |
SFG (N = 12) |
Leptospira spp. (N = 10) |
K. pneumoniae (N = 8) |
AFB (N = 7) |
E. coli (N = 5) |
|---|---|---|---|---|---|---|---|---|---|
| Fever | 95 (89%) | 21 (91%) | 20 (95%) | 15 (93.75%) | 11 (92%) | 9 (90%) | 6 (75%) | 7 (100%) | 5 (100%) |
| Rigors | 60 (56%)* | 19 (83%) | 17 (81%) | 13 (81.25%) |
9 (75%) | 8 (80%) | 4 (50%) | 7 (100%) | 4 (80%) |
| Sweat | 72 (67%) | 17 (74%) | 14 (67%) | 13 (81.25%) | 8 (67%) | 8 (80%) | 6 (75%) | 3 (43%) | 3 (60%) |
| Dizzy | 37 (35%)* | 13 (57%) | 9 (43%) | 8 (50%) | 5 (42%) | 5 (50%) | 5 (63%) | 4 (57%) | 3 (60%) |
| Headache | 68 (64%) | 15 (65%) | 14 (67%) | 12 (75%) | 8 (67%) | 4 (40%) | 6 (75%) | 3 (43%) | 3 (60%) |
| Retro-orbital pain | 23 (22%) | 7 (30%) | 6 (29%) | 8 (55%)* | 2 (17%) | 1 (10%) | 3 (38%) | 1 (14%) | 2 (40%) |
| Blurred vision | 41 (38%) | 8 (35%) | 10 (48%) | 13 (81.25%)* | 5 (42%) | 5 (50%) | 2 (25%) | 3 (43%) | 2 (40%) |
| Hearing | 26 (24%) | 4 (17%) | 6 (29%) | 6 (37.5%) | 5 (42%) | 2 (20%) | 3 (38%) | 2 (29%) | 1 (20%) |
| Confusion | 20 (19%) | 3 (13%) | 4 (19%) | 4 (25%) | 2 (17%) | 4 (40%)* | 0 | 0 | 0 |
| Stiff neck | 12 (11%) | 1 (4%) | 0 | 2 (12.5%) | 0 | 0 | 1 (13%) | 0 | 0 |
| Sore throat | 23 (22%) | 6 (26%) | 11 (52%)* | 9 (56.25%)* | 6 (50%) | 4 (40%) | 3 (38%) | 3 (43%) | 0 |
| Swollen glands | 2 (2%) | 1 (4%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shortness of breath | 71 (66%) | 15 (65%) | 15 (71%) | 13 (81.25%) | 8 (67%) | 6 (60%) | 8 (100%) | 7 (100%) | 4 (80%) |
| Palpitation | 41 (38%) | 11 (48%) | 9 (43%) | 9 (56.25%) | 9 (75%)* | 4 (40%) | 4 (50%) | 3 (43%) | 4 (80%) |
| Cough | 55 (51%)* | 16 (70%) | 14 (67%) | 12 (75%) | 10 (83%) | 5 (50%) | 8 (100%)* | 7 (100%)* | 4 (80%) |
| Join pain | 34 (32%) | 7 (30%) | 10 (48%) | 8 (50%) | 6 (50%) | 5 (50%) | 1 (13%) | 1 (14%) | 2 (40%) |
| Muscle soreness | 42 (39%) | 10 (43%) | 13 (62%) | 16 (100%)* | 7 (58%) | 4 (40%) | 3 (38%) | 3 (43%) | 1 (20%) |
| Fatigue | 92 (86%) | 19 (83%) | 19 (90%) | 14 (87.5%) | 10 (83%) | 8 (80%) | 8 (100%) | 7 (100%) | 5 (100%) |
| Anorexia | 80 (75%) | 16 (70%) | 16 (76%) | 11 (68.75%) | 10 (83%) | 7 (70%) | 8 (100%) | 6 (86%) | 5 (100%) |
| Abdominal pain | 54 (50%) | 11 (48%) | 14 (67%) | 14 (87.5%)* | 8 (67%) | 8 (80%) | 4 (50%) | 2 (29%) | 4 (80%) |
| Nausea | 41 (38%) | 7 (30%) | 7 (33%) | 7 (43.75%) | 4 (33%) | 2 (20%) | 1 (13%) | 3 (43%) | 1 (20%) |
| Diarrhea | 19 (18%) | 7 (30%) | 4 (19%) | 4 (25%) | 4 (33%) | 1 (10%) | 0 | 1 (14%) | 0 |
| Swelling | 7 (7%) | 1 (4%) | 3 (14%) | 2 (12.5%) | 1 (8%) | 0 | 1 (13%) | 0 | 1 (20%) |
| Itching | 6 (6%) | 1 (4%) | 3 (14%) | 3 (18.75%) | 1 (8%) | 0 | 0 | 0 | 0 |
| Rash | 4 (4%) | 1 (4%) | 2 (10%) | 3 (18.75%)* | 1 (8%) | 0 | 0 | 0 | 0 |
| Skin lesions | 5 (5%) | 1 (4%) | 1 (5%) | 0 | 0 | 0 | 1 (13%) | 0 | 0 |
| Unusual bleeding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |